JB Chemicals & Pharmaceuticals Ltd (JBCPL) has successfully completed transactions for the acquisition of a portfolio of brands from Sanzyme Private Limited (SPL).
The company’s board at its meeting held on January 25, 2022, had given approval for the acquisition of a portfolio of brands, for use and commercialization within India, from Sanzyme Private Limited (SPL).
JBCPL is one of the fastest-growing pharmaceutical companies in India and Sanzyme is a leading player in the probiotics and reproductive health segment in the country. The transaction was valued at Rs628cr.
At around 9.42 AM, JB Chemicals & Pharmaceuticals Ltd was trading at Rs1,773.15 per piece down by Rs10.4 or 0.58% from its previous closing of Rs1,783.55 per piece on the BSE.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
